RU2004134447A -
APPLICATION OF THE PRODUCT "MEXICOR" (2-Ethyl-6-methyl-3-hydroxypyridine succinate) for the treatment of nephritis and nephropathy
- Google Patents
APPLICATION OF THE PRODUCT "MEXICOR" (2-Ethyl-6-methyl-3-hydroxypyridine succinate) for the treatment of nephritis and nephropathy
Download PDF
Info
Publication number
RU2004134447A
RU2004134447ARU2004134447/15ARU2004134447ARU2004134447ARU 2004134447 ARU2004134447 ARU 2004134447ARU 2004134447/15 ARU2004134447/15 ARU 2004134447/15ARU 2004134447 ARU2004134447 ARU 2004134447ARU 2004134447 ARU2004134447 ARU 2004134447A
Общество с ограниченной ответственностью "ЭКОФАРМИНВЕСТ" (RU)
Общество с ограниченной ответственностью "Экофарминвест"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ЭКОФАРМИНВЕСТ" (RU), Общество с ограниченной ответственностью "Экофарминвест"filedCriticalОбщество с ограниченной ответственностью "ЭКОФАРМИНВЕСТ" (RU)
Priority to RU2004134447/15ApriorityCriticalpatent/RU2290930C2/en
Publication of RU2004134447ApublicationCriticalpatent/RU2004134447A/en
Application grantedgrantedCritical
Publication of RU2290930C2publicationCriticalpatent/RU2290930C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Claims (1)
Применение препарата Мексикор (2-этил-6-метил-3-оксипиридина сукцината) впервые в качестве лекарственного препарата у больных нефритами и нефропатиями на фоне традиционной терапии, включающей реолитики, антикоагулянты и антиагреганты, ингибиторы АПФ и противовоспалительные средства.The use of Mexicor (2-ethyl-6-methyl-3-hydroxypyridine succinate) for the first time as a drug in patients with nephritis and nephropathy on the background of traditional therapy, including rheolytics, anticoagulants and antiplatelet agents, ACE inhibitors and anti-inflammatory drugs.
RU2004134447/15A2004-11-262004-11-26Application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy
RU2290930C2
(en)
PHARMACEUTICAL COMBINATION THAT INCLUDES 8A) MELATONIN AND MELATONINE AGONISTS, AND NICOTINE AND NICOTINE RECEIVING AGONISTS; PHARMACEUTICAL KIT, AND; USE IN THE TREATMENT OF INSOMNIUM, COGNITIVE DIFFICULTIES AND MEMORY DIFFICULTIES; FARMACEU KIT
COMPOUNDS DERIVED FROM 3- (4-METOXI-7-MORFOLIN-4-IL-BENZOTIAZOL-2-IL) -1,1-DISUSTITUDE-UREA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF THE COMPOUND IN THE TREATMENT OF RELATED DISEASES CO